What is the recommended serum Thyroid-Stimulating Hormone (TSH) cutoff in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Serum TSH Cutoff in Pregnancy

Pregnancy-Specific TSH Reference Ranges

For pregnant women, use a first-trimester TSH upper limit of 4.0 mIU/L when population-specific reference ranges are not available, or alternatively 0.5 mIU/L below the non-pregnant upper limit. 1

The 2017 American Thyroid Association guidelines revised their previous stricter recommendations after recognizing that the earlier cutoffs (0.1-2.5 mIU/L for first trimester) led to overdiagnosis and unnecessary treatment. 1 The current evidence-based approach acknowledges that:

  • TSH values vary by gestational week within the first trimester, with non-pregnant reference ranges appropriate up to week 6, and TSH levels approximately 0.4 mIU/L lower than non-pregnancy upper limits during weeks 9-12. 2

  • The lower limit remains 0.1 mIU/L throughout the first trimester. 2

Treatment Thresholds During Pregnancy

Treat subclinical hypothyroidism in pregnancy when TSH exceeds the trimester-specific upper limit to restore TSH to the reference range. 3

For women with known hypothyroidism on levothyroxine:

  • Target preconception TSH below 1.2 mIU/L to minimize the need for dose increases during pregnancy. 3, 4 When preconception TSH is 1.2-2.4 mIU/L, 50% of patients require dose increases during pregnancy, compared to only 17.2% when preconception TSH is <1.2 mIU/L. 4

  • Increase levothyroxine dose by 25-50% immediately upon confirmation of pregnancy in women with pre-existing hypothyroidism, as requirements typically increase substantially during early pregnancy. 5

Clinical Significance of TSH Elevation in Pregnancy

Even mild TSH elevation (2.5-5.0 mIU/L) in thyroid antibody-negative women is associated with increased pregnancy loss. 6 A large prospective study of 4,123 women demonstrated pregnancy loss rates of 6.1% in women with TSH 2.5-5.0 mIU/L versus 3.6% in women with TSH <2.5 mIU/L (p=0.006). 6

Untreated maternal hypothyroidism increases risks of:

  • Preeclampsia 3
  • Low birth weight 3
  • Impaired fetal neuropsychological development 3

Monitoring Protocol During Pregnancy

Check thyroid function tests every 4-6 weeks during the first half of pregnancy and at least once during the second half. 5

For isolated maternal hypothyroxinemia (low T4 with normal TSH), treat with levothyroxine to restore T4 levels to normal range despite normal TSH, as this pattern may adversely affect fetal development. 3

Critical Pitfalls to Avoid

  • Do not apply uniform TSH limits across the entire first trimester, as this leads to misclassification and unnecessary treatment given the week-by-week variation in early pregnancy. 2

  • Do not use the outdated 2011 ATA cutoff of 2.5 mIU/L as an absolute treatment threshold unless population-specific data support it, as this was revised in 2017 due to overtreatment concerns. 1

  • Ensure women with hypothyroidism achieve optimal thyroid function before conception rather than waiting until pregnancy is confirmed, as early fetal neurologic development depends on adequate maternal thyroid hormone. 5, 3

References

Research

Thyroid-Stimulating Hormone Values in Pregnancy: Cutoff Controversy Continues?

Journal of obstetrics and gynaecology of India, 2019

Guideline

Levothyroxine Management During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Levothyroxine Use During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.